Ticker Details
Nurix Therapeutics, Inc.
IPO Date:	July 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.67 | 3.46%
Avg Daily Range (30 D):	$0.35 | 2.27%
Avg Daily Range (90 D):	$0.43 | 2.47%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	.98M
Avg Daily Volume (90 D):	1.05M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	1,984
Avg Institutional Trade:	$2.07M
Avg Institutional Trade (30 D):	$3.05M
Avg Institutional Trade (90 D):	$2.76M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$3.53M
Avg Closing Trade (90 D):	$3.98M
Avg Closing Volume:	118.85K

News

Apr 8, 2026 @ 10:00 AM Nurix Therapeutics Reports First Quarter 2026 Fina... Source: Na

Feb 22, 2026 @ 6:12 PM Nurix Stock Is Down 6% This Past Year, but One Bio... Source: Jonathan Ponciano

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Dec 6, 2025 @ 2:30 PM Nurix Therapeutics Presents New Data Demonstrating... Source: Nurix Therapeutics

Dec 1, 2025 @ 12:00 PM Nurix Therapeutics Announces Webcast to Review New... Source: Nurix Therapeutics

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-3.17	$-.79
Diluted EPS	$-3.17	$-.79
Revenue	$71.78M	$6.25M
Gross Profit
Net Income / Loss	$-295.28M	$-87.17M
Operating Income / Loss	$-315.3M	$-92.5M
Cost of Revenue
Net Cash Flow	$-4.65M	$-175.77M
PE Ratio